nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.182	1	CrCtD
Doxorubicin—AURKA—peripheral nervous system neoplasm	0.0911	0.898	CbGaD
Doxorubicin—Topoisomerase Inhibitors—Topotecan—peripheral nervous system neoplasm	0.088	0.333	CiPCiCtD
Doxorubicin—Anthracyclines—Epirubicin—peripheral nervous system neoplasm	0.0773	0.292	CiPCiCtD
Doxorubicin—Topoisomerase Inhibitors—Etoposide—peripheral nervous system neoplasm	0.0587	0.222	CiPCiCtD
Doxorubicin—bone cancer—peripheral nervous system neoplasm	0.0527	0.386	CtDrD
Doxorubicin—muscle cancer—peripheral nervous system neoplasm	0.0466	0.341	CtDrD
Doxorubicin—Topoisomerase Inhibitors—Epirubicin—peripheral nervous system neoplasm	0.0404	0.153	CiPCiCtD
Doxorubicin—Valrubicin—Epirubicin—peripheral nervous system neoplasm	0.0384	0.333	CrCrCtD
Doxorubicin—Idarubicin—Epirubicin—peripheral nervous system neoplasm	0.0384	0.333	CrCrCtD
Doxorubicin—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	0.0384	0.333	CrCrCtD
Doxorubicin—sarcoma—peripheral nervous system neoplasm	0.0372	0.272	CtDrD
Doxorubicin—YWHAG—Epirubicin—peripheral nervous system neoplasm	0.016	0.12	CbGbCtD
Doxorubicin—AURKA—Epirubicin—peripheral nervous system neoplasm	0.016	0.12	CbGbCtD
Doxorubicin—DHCR7—Epirubicin—peripheral nervous system neoplasm	0.016	0.12	CbGbCtD
Doxorubicin—RALBP1—Vincristine—peripheral nervous system neoplasm	0.0108	0.0814	CbGbCtD
Doxorubicin—ABCB1—peripheral nervous system neoplasm	0.0104	0.103	CbGaD
Doxorubicin—ABCC6—Dactinomycin—peripheral nervous system neoplasm	0.00844	0.0635	CbGbCtD
Doxorubicin—NQO1—Cisplatin—peripheral nervous system neoplasm	0.0058	0.0436	CbGbCtD
Doxorubicin—ABCC6—Cisplatin—peripheral nervous system neoplasm	0.00485	0.0365	CbGbCtD
Doxorubicin—ABCC6—Etoposide—peripheral nervous system neoplasm	0.00477	0.0358	CbGbCtD
Doxorubicin—ABCC10—Vincristine—peripheral nervous system neoplasm	0.00397	0.0299	CbGbCtD
Doxorubicin—ABCC10—Etoposide—peripheral nervous system neoplasm	0.00364	0.0274	CbGbCtD
Doxorubicin—TOP2A—Epirubicin—peripheral nervous system neoplasm	0.00325	0.0245	CbGbCtD
Doxorubicin—XDH—Cisplatin—peripheral nervous system neoplasm	0.00303	0.0228	CbGbCtD
Doxorubicin—TOP2A—Etoposide—peripheral nervous system neoplasm	0.00254	0.0191	CbGbCtD
Doxorubicin—ABCC3—Vincristine—peripheral nervous system neoplasm	0.0025	0.0188	CbGbCtD
Doxorubicin—ABCC1—Dactinomycin—peripheral nervous system neoplasm	0.00249	0.0187	CbGbCtD
Doxorubicin—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0024	0.0181	CbGbCtD
Doxorubicin—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.00233	0.0175	CbGbCtD
Doxorubicin—ABCC3—Etoposide—peripheral nervous system neoplasm	0.00229	0.0172	CbGbCtD
Doxorubicin—ABCB11—Vincristine—peripheral nervous system neoplasm	0.00216	0.0162	CbGbCtD
Doxorubicin—ABCC1—Epirubicin—peripheral nervous system neoplasm	0.0018	0.0136	CbGbCtD
Doxorubicin—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.00167	0.0125	CbGbCtD
Doxorubicin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.00157	0.0118	CbGbCtD
Doxorubicin—ABCC1—Vincristine—peripheral nervous system neoplasm	0.00153	0.0115	CbGbCtD
Doxorubicin—ABCC1—Etoposide—peripheral nervous system neoplasm	0.00141	0.0106	CbGbCtD
Doxorubicin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00114	0.00854	CbGbCtD
Doxorubicin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00796	CbGbCtD
Doxorubicin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00104	0.00782	CbGbCtD
Doxorubicin—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00103	0.00772	CbGbCtD
Doxorubicin—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.000957	0.0072	CbGbCtD
Doxorubicin—ABCG2—Etoposide—peripheral nervous system neoplasm	0.000941	0.00707	CbGbCtD
Doxorubicin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.000867	0.00652	CbGbCtD
Doxorubicin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.000867	0.00652	CbGbCtD
Doxorubicin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.000673	0.00506	CbGbCtD
Doxorubicin—Epirubicin—AURKA—peripheral nervous system neoplasm	0.000657	0.925	CrCbGaD
Doxorubicin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.000601	0.00452	CbGbCtD
Doxorubicin—ABCB8—ganglion—peripheral nervous system neoplasm	0.000597	0.0796	CbGeAlD
Doxorubicin—ABCB8—tongue—peripheral nervous system neoplasm	0.000591	0.0788	CbGeAlD
Doxorubicin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00052	0.00391	CbGbCtD
Doxorubicin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.000483	0.00363	CbGbCtD
Doxorubicin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00037	0.00278	CbGbCtD
Doxorubicin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.000345	0.0026	CbGbCtD
Doxorubicin—NOS1—nerve—peripheral nervous system neoplasm	0.00034	0.0454	CbGeAlD
Doxorubicin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.000339	0.00255	CbGbCtD
Doxorubicin—NOS1—ganglion—peripheral nervous system neoplasm	0.000336	0.0448	CbGeAlD
Doxorubicin—NDUFS3—ganglion—peripheral nervous system neoplasm	0.00033	0.044	CbGeAlD
Doxorubicin—CBR3—trigeminal ganglion—peripheral nervous system neoplasm	0.000282	0.0376	CbGeAlD
Doxorubicin—CBR3—parotid gland—peripheral nervous system neoplasm	0.000266	0.0355	CbGeAlD
Doxorubicin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000222	0.00167	CbGbCtD
Doxorubicin—AKR1A1—trigeminal ganglion—peripheral nervous system neoplasm	0.000218	0.0291	CbGeAlD
Doxorubicin—AKR1A1—parotid gland—peripheral nervous system neoplasm	0.000206	0.0274	CbGeAlD
Doxorubicin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000203	0.00153	CbGbCtD
Doxorubicin—NQO1—ganglion—peripheral nervous system neoplasm	0.000194	0.0259	CbGeAlD
Doxorubicin—NDUFS2—trigeminal ganglion—peripheral nervous system neoplasm	0.000164	0.0219	CbGeAlD
Doxorubicin—NDUFS3—trigeminal ganglion—peripheral nervous system neoplasm	0.000162	0.0216	CbGeAlD
Doxorubicin—NDUFS2—parotid gland—peripheral nervous system neoplasm	0.000155	0.0206	CbGeAlD
Doxorubicin—DHCR7—trigeminal ganglion—peripheral nervous system neoplasm	0.000154	0.0205	CbGeAlD
Doxorubicin—NDUFS3—parotid gland—peripheral nervous system neoplasm	0.000153	0.0204	CbGeAlD
Doxorubicin—NOS1—brainstem—peripheral nervous system neoplasm	0.000146	0.0195	CbGeAlD
Doxorubicin—DHCR7—parotid gland—peripheral nervous system neoplasm	0.000145	0.0194	CbGeAlD
Doxorubicin—NDUFS3—brainstem—peripheral nervous system neoplasm	0.000143	0.0191	CbGeAlD
Doxorubicin—YWHAG—trigeminal ganglion—peripheral nervous system neoplasm	0.000141	0.0188	CbGeAlD
Doxorubicin—YWHAG—parotid gland—peripheral nervous system neoplasm	0.000133	0.0178	CbGeAlD
Doxorubicin—AURKA—Chlorambucil—Melphalan—peripheral nervous system neoplasm	0.000128	0.182	CbGdCrCtD
Doxorubicin—ABCB8—cerebellum—peripheral nervous system neoplasm	0.000128	0.0171	CbGeAlD
Doxorubicin—RALBP1—trigeminal ganglion—peripheral nervous system neoplasm	0.000128	0.017	CbGeAlD
Doxorubicin—CBR3—cerebellum—peripheral nervous system neoplasm	0.000123	0.0164	CbGeAlD
Doxorubicin—RALBP1—parotid gland—peripheral nervous system neoplasm	0.00012	0.0161	CbGeAlD
Doxorubicin—CBR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000119	0.0159	CbGeAlD
Doxorubicin—AKR1C3—trigeminal ganglion—peripheral nervous system neoplasm	0.000118	0.0157	CbGeAlD
Doxorubicin—CBR1—parotid gland—peripheral nervous system neoplasm	0.000112	0.015	CbGeAlD
Doxorubicin—AKR1C3—parotid gland—peripheral nervous system neoplasm	0.000111	0.0148	CbGeAlD
Doxorubicin—POR—trigeminal ganglion—peripheral nervous system neoplasm	0.000107	0.0143	CbGeAlD
Doxorubicin—POR—parotid gland—peripheral nervous system neoplasm	0.000101	0.0135	CbGeAlD
Doxorubicin—NQO1—trigeminal ganglion—peripheral nervous system neoplasm	9.55e-05	0.0127	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—peripheral nervous system neoplasm	9.51e-05	0.0127	CbGeAlD
Doxorubicin—NQO1—parotid gland—peripheral nervous system neoplasm	9e-05	0.012	CbGeAlD
Doxorubicin—AURKA—Irinotecan—Topotecan—peripheral nervous system neoplasm	8.92e-05	0.127	CbGdCrCtD
Doxorubicin—NDUFS7—cerebellum—peripheral nervous system neoplasm	8.64e-05	0.0115	CbGeAlD
Doxorubicin—ABCC10—trigeminal ganglion—peripheral nervous system neoplasm	8.53e-05	0.0114	CbGeAlD
Doxorubicin—ABCC10—parotid gland—peripheral nervous system neoplasm	8.04e-05	0.0107	CbGeAlD
Doxorubicin—NOS1—cerebellum—peripheral nervous system neoplasm	7.2e-05	0.00961	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—peripheral nervous system neoplasm	7.16e-05	0.00955	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—peripheral nervous system neoplasm	7.07e-05	0.00943	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Etoposide—peripheral nervous system neoplasm	7.04e-05	0.1	CbGdCrCtD
Doxorubicin—DHCR7—cerebellum—peripheral nervous system neoplasm	6.72e-05	0.00896	CbGeAlD
Doxorubicin—CBR3—Teniposide—Etoposide—peripheral nervous system neoplasm	6.34e-05	0.09	CbGdCrCtD
Doxorubicin—YWHAG—cerebellum—peripheral nervous system neoplasm	6.17e-05	0.00822	CbGeAlD
Doxorubicin—AKR1C3—Podofilox—Etoposide—peripheral nervous system neoplasm	6.15e-05	0.0874	CbGdCrCtD
Doxorubicin—ABCC1—parotid gland—peripheral nervous system neoplasm	5.69e-05	0.00758	CbGeAlD
Doxorubicin—RALBP1—cerebellum—peripheral nervous system neoplasm	5.57e-05	0.00743	CbGeAlD
Doxorubicin—Daunorubicin—ABCB1—peripheral nervous system neoplasm	5.31e-05	0.0748	CrCbGaD
Doxorubicin—CBR1—cerebellum—peripheral nervous system neoplasm	5.2e-05	0.00693	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—peripheral nervous system neoplasm	5.13e-05	0.00685	CbGeAlD
Doxorubicin—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	4.99e-05	0.00666	CbGeAlD
Doxorubicin—ABCG2—parotid gland—peripheral nervous system neoplasm	4.71e-05	0.00628	CbGeAlD
Doxorubicin—POR—cerebellum—peripheral nervous system neoplasm	4.69e-05	0.00625	CbGeAlD
Doxorubicin—AKR1C3—Vinblastine—Vincristine—peripheral nervous system neoplasm	4.23e-05	0.0601	CbGdCrCtD
Doxorubicin—NQO1—cerebellum—peripheral nervous system neoplasm	4.16e-05	0.00555	CbGeAlD
Doxorubicin—ABCC10—cerebellum—peripheral nervous system neoplasm	3.72e-05	0.00496	CbGeAlD
Doxorubicin—TOP2A—Irinotecan—Topotecan—peripheral nervous system neoplasm	3.41e-05	0.0484	CbGdCrCtD
Doxorubicin—AURKA—Teniposide—Etoposide—peripheral nervous system neoplasm	3.34e-05	0.0474	CbGdCrCtD
Doxorubicin—CBR3—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.0469	CbGdCrCtD
Doxorubicin—CBR3—Idarubicin—Epirubicin—peripheral nervous system neoplasm	3.3e-05	0.0469	CbGdCrCtD
Doxorubicin—CYP2D6—brainstem—peripheral nervous system neoplasm	3.03e-05	0.00404	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—peripheral nervous system neoplasm	2.92e-05	0.0039	CbGeAlD
Doxorubicin—ABCC1—cerebellum—peripheral nervous system neoplasm	2.63e-05	0.00351	CbGeAlD
Doxorubicin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	2.46e-05	0.00328	CbGeAlD
Doxorubicin—ABCG2—cerebellum—peripheral nervous system neoplasm	2.18e-05	0.0029	CbGeAlD
Doxorubicin—TOP2A—Vindesine—Vincristine—peripheral nervous system neoplasm	2.02e-05	0.0287	CbGdCrCtD
Doxorubicin—AURKA—Idarubicin—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.0247	CbGdCrCtD
Doxorubicin—AURKA—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	1.74e-05	0.0247	CbGdCrCtD
Doxorubicin—CYP2D6—cerebellum—peripheral nervous system neoplasm	1.49e-05	0.00199	CbGeAlD
Doxorubicin—TOP2A—Vinorelbine—Vincristine—peripheral nervous system neoplasm	1.28e-05	0.0181	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—peripheral nervous system neoplasm	1.28e-05	0.0181	CbGdCrCtD
Doxorubicin—TOP2A—Teniposide—Etoposide—peripheral nervous system neoplasm	1.28e-05	0.0181	CbGdCrCtD
Doxorubicin—ABCB1—cerebellum—peripheral nervous system neoplasm	1.07e-05	0.00143	CbGeAlD
Doxorubicin—TOP2A—Vinblastine—Vincristine—peripheral nervous system neoplasm	8.78e-06	0.0125	CbGdCrCtD
Doxorubicin—TOP2A—Idarubicin—Epirubicin—peripheral nervous system neoplasm	6.65e-06	0.00945	CbGdCrCtD
Doxorubicin—TOP2A—Daunorubicin—Epirubicin—peripheral nervous system neoplasm	6.65e-06	0.00945	CbGdCrCtD
Doxorubicin—Ataxia—Epirubicin—peripheral nervous system neoplasm	6.32e-06	0.000153	CcSEcCtD
Doxorubicin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	6.31e-06	0.000153	CcSEcCtD
Doxorubicin—Cough—Etoposide—peripheral nervous system neoplasm	6.3e-06	0.000153	CcSEcCtD
Doxorubicin—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	6.3e-06	0.000152	CcSEcCtD
Doxorubicin—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	6.3e-06	0.000152	CcSEcCtD
Doxorubicin—Headache—Topotecan—peripheral nervous system neoplasm	6.29e-06	0.000152	CcSEcCtD
Doxorubicin—Rash—Isotretinoin—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Rash—Tretinoin—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	6.28e-06	0.000152	CcSEcCtD
Doxorubicin—Fatigue—Vincristine—peripheral nervous system neoplasm	6.27e-06	0.000152	CcSEcCtD
Doxorubicin—Convulsion—Etoposide—peripheral nervous system neoplasm	6.26e-06	0.000151	CcSEcCtD
Doxorubicin—Vomiting—Melphalan—peripheral nervous system neoplasm	6.25e-06	0.000151	CcSEcCtD
Doxorubicin—Dehydration—Epirubicin—peripheral nervous system neoplasm	6.25e-06	0.000151	CcSEcCtD
Doxorubicin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	6.25e-06	0.000151	CcSEcCtD
Doxorubicin—Headache—Isotretinoin—peripheral nervous system neoplasm	6.24e-06	0.000151	CcSEcCtD
Doxorubicin—Headache—Tretinoin—peripheral nervous system neoplasm	6.24e-06	0.000151	CcSEcCtD
Doxorubicin—Hypertension—Etoposide—peripheral nervous system neoplasm	6.23e-06	0.000151	CcSEcCtD
Doxorubicin—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	6.22e-06	0.000151	CcSEcCtD
Doxorubicin—Pain—Vincristine—peripheral nervous system neoplasm	6.22e-06	0.000151	CcSEcCtD
Doxorubicin—Constipation—Vincristine—peripheral nervous system neoplasm	6.22e-06	0.000151	CcSEcCtD
Doxorubicin—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	6.22e-06	0.000151	CcSEcCtD
Doxorubicin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	6.21e-06	0.00015	CcSEcCtD
Doxorubicin—Rash—Melphalan—peripheral nervous system neoplasm	6.2e-06	0.00015	CcSEcCtD
Doxorubicin—Dermatitis—Melphalan—peripheral nervous system neoplasm	6.19e-06	0.00015	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	6.17e-06	0.000149	CcSEcCtD
Doxorubicin—Dry skin—Epirubicin—peripheral nervous system neoplasm	6.16e-06	0.000149	CcSEcCtD
Doxorubicin—Chest pain—Etoposide—peripheral nervous system neoplasm	6.15e-06	0.000149	CcSEcCtD
Doxorubicin—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	6.14e-06	0.000149	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	6.14e-06	0.000149	CcSEcCtD
Doxorubicin—Anorexia—Cisplatin—peripheral nervous system neoplasm	6.13e-06	0.000148	CcSEcCtD
Doxorubicin—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	6.12e-06	0.000148	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	6.11e-06	0.000148	CcSEcCtD
Doxorubicin—Discomfort—Etoposide—peripheral nervous system neoplasm	6.07e-06	0.000147	CcSEcCtD
Doxorubicin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	6.07e-06	0.000147	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	6.05e-06	0.000147	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	6.05e-06	0.000147	CcSEcCtD
Doxorubicin—Hypotension—Cisplatin—peripheral nervous system neoplasm	6.01e-06	0.000146	CcSEcCtD
Doxorubicin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	6.01e-06	0.000146	CcSEcCtD
Doxorubicin—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	6e-06	0.000145	CcSEcCtD
Doxorubicin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	6e-06	0.000145	CcSEcCtD
Doxorubicin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	5.97e-06	0.000144	CcSEcCtD
Doxorubicin—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	5.97e-06	0.000144	CcSEcCtD
Doxorubicin—Nausea—Topotecan—peripheral nervous system neoplasm	5.96e-06	0.000144	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	5.95e-06	0.000144	CcSEcCtD
Doxorubicin—Gastritis—Epirubicin—peripheral nervous system neoplasm	5.95e-06	0.000144	CcSEcCtD
Doxorubicin—Confusional state—Etoposide—peripheral nervous system neoplasm	5.94e-06	0.000144	CcSEcCtD
Doxorubicin—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	5.93e-06	0.000144	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	5.93e-06	0.000144	CcSEcCtD
Doxorubicin—Nausea—Tretinoin—peripheral nervous system neoplasm	5.92e-06	0.000143	CcSEcCtD
Doxorubicin—Nausea—Isotretinoin—peripheral nervous system neoplasm	5.92e-06	0.000143	CcSEcCtD
Doxorubicin—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	5.89e-06	0.000143	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	5.86e-06	0.000142	CcSEcCtD
Doxorubicin—Infection—Etoposide—peripheral nervous system neoplasm	5.85e-06	0.000142	CcSEcCtD
Doxorubicin—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	5.85e-06	0.000142	CcSEcCtD
Doxorubicin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	5.84e-06	0.000141	CcSEcCtD
Doxorubicin—Nausea—Melphalan—peripheral nervous system neoplasm	5.84e-06	0.000141	CcSEcCtD
Doxorubicin—Influenza—Epirubicin—peripheral nervous system neoplasm	5.81e-06	0.000141	CcSEcCtD
Doxorubicin—Asthma—Epirubicin—peripheral nervous system neoplasm	5.81e-06	0.000141	CcSEcCtD
Doxorubicin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	5.81e-06	0.000141	CcSEcCtD
Doxorubicin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	5.78e-06	0.00014	CcSEcCtD
Doxorubicin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	5.77e-06	0.00014	CcSEcCtD
Doxorubicin—Tachycardia—Etoposide—peripheral nervous system neoplasm	5.75e-06	0.000139	CcSEcCtD
Doxorubicin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	5.75e-06	0.000139	CcSEcCtD
Doxorubicin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	5.75e-06	0.000139	CcSEcCtD
Doxorubicin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	5.75e-06	0.000139	CcSEcCtD
Doxorubicin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	5.74e-06	0.000139	CcSEcCtD
Doxorubicin—Skin disorder—Etoposide—peripheral nervous system neoplasm	5.72e-06	0.000139	CcSEcCtD
Doxorubicin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	5.7e-06	0.000138	CcSEcCtD
Doxorubicin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	5.7e-06	0.000138	CcSEcCtD
Doxorubicin—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	5.66e-06	0.000137	CcSEcCtD
Doxorubicin—Anorexia—Etoposide—peripheral nervous system neoplasm	5.62e-06	0.000136	CcSEcCtD
Doxorubicin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	5.59e-06	0.000135	CcSEcCtD
Doxorubicin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	5.59e-06	0.000135	CcSEcCtD
Doxorubicin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.57e-06	0.000135	CcSEcCtD
Doxorubicin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	5.56e-06	0.000135	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.55e-06	0.000134	CcSEcCtD
Doxorubicin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	5.52e-06	0.000134	CcSEcCtD
Doxorubicin—Hypotension—Etoposide—peripheral nervous system neoplasm	5.51e-06	0.000133	CcSEcCtD
Doxorubicin—Pain—Cisplatin—peripheral nervous system neoplasm	5.5e-06	0.000133	CcSEcCtD
Doxorubicin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	5.43e-06	0.000132	CcSEcCtD
Doxorubicin—Dysuria—Epirubicin—peripheral nervous system neoplasm	5.43e-06	0.000132	CcSEcCtD
Doxorubicin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	5.42e-06	0.000131	CcSEcCtD
Doxorubicin—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	5.4e-06	0.000131	CcSEcCtD
Doxorubicin—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	5.37e-06	0.00013	CcSEcCtD
Doxorubicin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	5.36e-06	0.00013	CcSEcCtD
Doxorubicin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	5.34e-06	0.000129	CcSEcCtD
Doxorubicin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	5.3e-06	0.000128	CcSEcCtD
Doxorubicin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.3e-06	0.000128	CcSEcCtD
Doxorubicin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.29e-06	0.000128	CcSEcCtD
Doxorubicin—Weight increased—Epirubicin—peripheral nervous system neoplasm	5.29e-06	0.000128	CcSEcCtD
Doxorubicin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	5.26e-06	0.000127	CcSEcCtD
Doxorubicin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	5.25e-06	0.000127	CcSEcCtD
Doxorubicin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	5.24e-06	0.000127	CcSEcCtD
Doxorubicin—Somnolence—Etoposide—peripheral nervous system neoplasm	5.24e-06	0.000127	CcSEcCtD
Doxorubicin—Asthenia—Vincristine—peripheral nervous system neoplasm	5.22e-06	0.000126	CcSEcCtD
Doxorubicin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	5.21e-06	0.000126	CcSEcCtD
Doxorubicin—Infestation—Epirubicin—peripheral nervous system neoplasm	5.18e-06	0.000125	CcSEcCtD
Doxorubicin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	5.18e-06	0.000125	CcSEcCtD
Doxorubicin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	5.18e-06	0.000125	CcSEcCtD
Doxorubicin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.18e-06	0.000125	CcSEcCtD
Doxorubicin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.17e-06	0.000125	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.14e-06	0.000124	CcSEcCtD
Doxorubicin—Rash—Dactinomycin—peripheral nervous system neoplasm	5.13e-06	0.000124	CcSEcCtD
Doxorubicin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.12e-06	0.000124	CcSEcCtD
Doxorubicin—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.09e-06	0.000123	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.09e-06	0.000123	CcSEcCtD
Doxorubicin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.09e-06	0.000123	CcSEcCtD
Doxorubicin—Fatigue—Etoposide—peripheral nervous system neoplasm	5.08e-06	0.000123	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.08e-06	0.000123	CcSEcCtD
Doxorubicin—Jaundice—Epirubicin—peripheral nervous system neoplasm	5.05e-06	0.000122	CcSEcCtD
Doxorubicin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.05e-06	0.000122	CcSEcCtD
Doxorubicin—Pain—Etoposide—peripheral nervous system neoplasm	5.04e-06	0.000122	CcSEcCtD
Doxorubicin—Constipation—Etoposide—peripheral nervous system neoplasm	5.04e-06	0.000122	CcSEcCtD
Doxorubicin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.03e-06	0.000122	CcSEcCtD
Doxorubicin—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	5.03e-06	0.000122	CcSEcCtD
Doxorubicin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	4.99e-06	0.000121	CcSEcCtD
Doxorubicin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	4.98e-06	0.000121	CcSEcCtD
Doxorubicin—Sweating—Epirubicin—peripheral nervous system neoplasm	4.97e-06	0.00012	CcSEcCtD
Doxorubicin—Haematuria—Epirubicin—peripheral nervous system neoplasm	4.94e-06	0.00012	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	4.9e-06	0.000119	CcSEcCtD
Doxorubicin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	4.89e-06	0.000118	CcSEcCtD
Doxorubicin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	4.86e-06	0.000118	CcSEcCtD
Doxorubicin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	4.86e-06	0.000118	CcSEcCtD
Doxorubicin—Nausea—Dactinomycin—peripheral nervous system neoplasm	4.84e-06	0.000117	CcSEcCtD
Doxorubicin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	4.83e-06	0.000117	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	4.82e-06	0.000117	CcSEcCtD
Doxorubicin—Dizziness—Vincristine—peripheral nervous system neoplasm	4.81e-06	0.000116	CcSEcCtD
Doxorubicin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	4.8e-06	0.000116	CcSEcCtD
Doxorubicin—Rash—Alitretinoin—peripheral nervous system neoplasm	4.76e-06	0.000115	CcSEcCtD
Doxorubicin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	4.76e-06	0.000115	CcSEcCtD
Doxorubicin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	4.74e-06	0.000115	CcSEcCtD
Doxorubicin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	4.73e-06	0.000115	CcSEcCtD
Doxorubicin—Headache—Alitretinoin—peripheral nervous system neoplasm	4.73e-06	0.000115	CcSEcCtD
Doxorubicin—Urticaria—Etoposide—peripheral nervous system neoplasm	4.68e-06	0.000113	CcSEcCtD
Doxorubicin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	4.67e-06	0.000113	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—ENO2—peripheral nervous system neoplasm	4.67e-06	0.000266	CbGpPWpGaD
Doxorubicin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	4.66e-06	0.000113	CcSEcCtD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	4.66e-06	0.000265	CbGpPWpGaD
Doxorubicin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	4.66e-06	0.000113	CcSEcCtD
Doxorubicin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	4.66e-06	0.000113	CcSEcCtD
Doxorubicin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.65e-06	0.000113	CcSEcCtD
Doxorubicin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	4.65e-06	0.000113	CcSEcCtD
Doxorubicin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	4.63e-06	0.000112	CcSEcCtD
Doxorubicin—Vomiting—Vincristine—peripheral nervous system neoplasm	4.63e-06	0.000112	CcSEcCtD
Doxorubicin—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.62e-06	0.000112	CcSEcCtD
Doxorubicin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	4.61e-06	0.000112	CcSEcCtD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.61e-06	0.000262	CbGpPWpGaD
Doxorubicin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	4.59e-06	0.000111	CcSEcCtD
Doxorubicin—Rash—Vincristine—peripheral nervous system neoplasm	4.59e-06	0.000111	CcSEcCtD
Doxorubicin—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.58e-06	0.000111	CcSEcCtD
Doxorubicin—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	4.58e-06	0.000111	CcSEcCtD
Doxorubicin—RALBP1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.57e-06	0.00026	CbGpPWpGaD
Doxorubicin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	4.57e-06	0.000111	CcSEcCtD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.56e-06	0.00026	CbGpPWpGaD
Doxorubicin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	4.56e-06	0.00011	CcSEcCtD
Doxorubicin—Headache—Vincristine—peripheral nervous system neoplasm	4.56e-06	0.00011	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	4.54e-06	0.000259	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.51e-06	0.000256	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—NRAS—peripheral nervous system neoplasm	4.5e-06	0.000256	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SLC2A1—peripheral nervous system neoplasm	4.49e-06	0.000256	CbGpPWpGaD
Doxorubicin—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.48e-06	0.000109	CcSEcCtD
Doxorubicin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.48e-06	0.000108	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.41e-06	0.000251	CbGpPWpGaD
Doxorubicin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.4e-06	0.000107	CcSEcCtD
Doxorubicin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.4e-06	0.000106	CcSEcCtD
Doxorubicin—NOS3—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.39e-06	0.00025	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.35e-06	0.000247	CbGpPWpGaD
Doxorubicin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.35e-06	0.000105	CcSEcCtD
Doxorubicin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.34e-06	0.000105	CcSEcCtD
Doxorubicin—XDH—Metabolism—ENO2—peripheral nervous system neoplasm	4.34e-06	0.000247	CbGpPWpGaD
Doxorubicin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.34e-06	0.000105	CcSEcCtD
Doxorubicin—Nausea—Vincristine—peripheral nervous system neoplasm	4.32e-06	0.000105	CcSEcCtD
Doxorubicin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.32e-06	0.000104	CcSEcCtD
Doxorubicin—Flushing—Epirubicin—peripheral nervous system neoplasm	4.32e-06	0.000104	CcSEcCtD
Doxorubicin—AURKA—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	4.31e-06	0.000245	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	4.31e-06	0.000245	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.25e-06	0.000242	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	4.24e-06	0.000241	CbGpPWpGaD
Doxorubicin—Asthenia—Etoposide—peripheral nervous system neoplasm	4.23e-06	0.000102	CcSEcCtD
Doxorubicin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.22e-06	0.000102	CcSEcCtD
Doxorubicin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.2e-06	0.000102	CcSEcCtD
Doxorubicin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.19e-06	0.000101	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.19e-06	0.000238	CbGpPWpGaD
Doxorubicin—Chills—Epirubicin—peripheral nervous system neoplasm	4.17e-06	0.000101	CcSEcCtD
Doxorubicin—Pruritus—Etoposide—peripheral nervous system neoplasm	4.17e-06	0.000101	CcSEcCtD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.17e-06	0.000237	CbGpPWpGaD
Doxorubicin—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.15e-06	0.000101	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.14e-06	0.000235	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.13e-06	0.000235	CbGpPWpGaD
Doxorubicin—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.11e-06	9.95e-05	CcSEcCtD
Doxorubicin—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.09e-06	9.9e-05	CcSEcCtD
Doxorubicin—NQO1—Metabolism—BCHE—peripheral nervous system neoplasm	4.09e-06	0.000233	CbGpPWpGaD
Doxorubicin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.07e-06	9.86e-05	CcSEcCtD
Doxorubicin—Rash—Cisplatin—peripheral nervous system neoplasm	4.06e-06	9.82e-05	CcSEcCtD
Doxorubicin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.05e-06	9.81e-05	CcSEcCtD
Doxorubicin—Erythema—Epirubicin—peripheral nervous system neoplasm	4.05e-06	9.8e-05	CcSEcCtD
Doxorubicin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.05e-06	9.8e-05	CcSEcCtD
Doxorubicin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.03e-06	9.76e-05	CcSEcCtD
Doxorubicin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.03e-06	0.000229	CbGpPWpGaD
Doxorubicin—Flatulence—Epirubicin—peripheral nervous system neoplasm	3.99e-06	9.66e-05	CcSEcCtD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.98e-06	0.000226	CbGpPWpGaD
Doxorubicin—Tension—Epirubicin—peripheral nervous system neoplasm	3.97e-06	9.62e-05	CcSEcCtD
Doxorubicin—ABCC1—Metabolism—GNS—peripheral nervous system neoplasm	3.97e-06	0.000226	CbGpPWpGaD
Doxorubicin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	3.96e-06	9.6e-05	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—BCHE—peripheral nervous system neoplasm	3.95e-06	0.000224	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ENO2—peripheral nervous system neoplasm	3.95e-06	0.000224	CbGpPWpGaD
Doxorubicin—Nervousness—Epirubicin—peripheral nervous system neoplasm	3.93e-06	9.52e-05	CcSEcCtD
Doxorubicin—Back pain—Epirubicin—peripheral nervous system neoplasm	3.92e-06	9.48e-05	CcSEcCtD
Doxorubicin—NQO1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.9e-06	0.000222	CbGpPWpGaD
Doxorubicin—Dizziness—Etoposide—peripheral nervous system neoplasm	3.9e-06	9.43e-05	CcSEcCtD
Doxorubicin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	3.89e-06	9.42e-05	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.87e-06	0.00022	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.87e-06	0.00022	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—peripheral nervous system neoplasm	3.85e-06	0.000219	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—TH—peripheral nervous system neoplasm	3.84e-06	0.000219	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.84e-06	0.000218	CbGpPWpGaD
Doxorubicin—Nausea—Cisplatin—peripheral nervous system neoplasm	3.82e-06	9.25e-05	CcSEcCtD
Doxorubicin—Vision blurred—Epirubicin—peripheral nervous system neoplasm	3.81e-06	9.24e-05	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.81e-06	0.000217	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NME1—peripheral nervous system neoplasm	3.8e-06	0.000216	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SLC2A1—peripheral nervous system neoplasm	3.8e-06	0.000216	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.76e-06	0.000214	CbGpPWpGaD
Doxorubicin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	3.76e-06	9.09e-05	CcSEcCtD
Doxorubicin—Vomiting—Etoposide—peripheral nervous system neoplasm	3.75e-06	9.07e-05	CcSEcCtD
Doxorubicin—Anaemia—Epirubicin—peripheral nervous system neoplasm	3.74e-06	9.06e-05	CcSEcCtD
Doxorubicin—Agitation—Epirubicin—peripheral nervous system neoplasm	3.72e-06	9.01e-05	CcSEcCtD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.72e-06	0.000212	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	3.72e-06	0.000211	CbGpPWpGaD
Doxorubicin—Rash—Etoposide—peripheral nervous system neoplasm	3.72e-06	9e-05	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.71e-06	8.99e-05	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—TH—peripheral nervous system neoplasm	3.71e-06	0.000211	CbGpPWpGaD
Doxorubicin—Headache—Etoposide—peripheral nervous system neoplasm	3.69e-06	8.94e-05	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.68e-06	0.000209	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—BCHE—peripheral nervous system neoplasm	3.67e-06	0.000209	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—COX2—peripheral nervous system neoplasm	3.66e-06	0.000208	CbGpPWpGaD
Doxorubicin—Malaise—Epirubicin—peripheral nervous system neoplasm	3.65e-06	8.84e-05	CcSEcCtD
Doxorubicin—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.64e-06	0.000207	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.64e-06	0.000207	CbGpPWpGaD
Doxorubicin—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.64e-06	8.8e-05	CcSEcCtD
Doxorubicin—Syncope—Epirubicin—peripheral nervous system neoplasm	3.63e-06	8.79e-05	CcSEcCtD
Doxorubicin—NOS1—Disease—PTPN11—peripheral nervous system neoplasm	3.63e-06	0.000206	CbGpPWpGaD
Doxorubicin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	3.62e-06	8.77e-05	CcSEcCtD
Doxorubicin—Palpitations—Epirubicin—peripheral nervous system neoplasm	3.58e-06	8.66e-05	CcSEcCtD
Doxorubicin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.56e-06	8.61e-05	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism—COX2—peripheral nervous system neoplasm	3.54e-06	0.000202	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.54e-06	0.000201	CbGpPWpGaD
Doxorubicin—Cough—Epirubicin—peripheral nervous system neoplasm	3.53e-06	8.55e-05	CcSEcCtD
Doxorubicin—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.51e-06	8.49e-05	CcSEcCtD
Doxorubicin—Nausea—Etoposide—peripheral nervous system neoplasm	3.5e-06	8.47e-05	CcSEcCtD
Doxorubicin—XDH—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.5e-06	0.000199	CbGpPWpGaD
Doxorubicin—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.49e-06	8.46e-05	CcSEcCtD
Doxorubicin—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	3.49e-06	0.000199	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—TH—peripheral nervous system neoplasm	3.45e-06	0.000196	CbGpPWpGaD
Doxorubicin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.45e-06	8.34e-05	CcSEcCtD
Doxorubicin—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.45e-06	8.34e-05	CcSEcCtD
Doxorubicin—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.45e-06	8.34e-05	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—TP53—peripheral nervous system neoplasm	3.44e-06	0.000196	CbGpPWpGaD
Doxorubicin—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.43e-06	8.31e-05	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.42e-06	8.29e-05	CcSEcCtD
Doxorubicin—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.4e-06	8.24e-05	CcSEcCtD
Doxorubicin—NOS2—Hemostasis—NRAS—peripheral nervous system neoplasm	3.4e-06	0.000193	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.39e-06	0.000193	CbGpPWpGaD
Doxorubicin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.37e-06	8.16e-05	CcSEcCtD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.37e-06	0.000192	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	3.37e-06	0.000192	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	3.35e-06	0.00019	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—BCHE—peripheral nervous system neoplasm	3.33e-06	0.00019	CbGpPWpGaD
Doxorubicin—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.33e-06	8.06e-05	CcSEcCtD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.33e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PPP3R1—peripheral nervous system neoplasm	3.31e-06	0.000189	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.31e-06	0.000188	CbGpPWpGaD
Doxorubicin—Oedema—Epirubicin—peripheral nervous system neoplasm	3.3e-06	8e-05	CcSEcCtD
Doxorubicin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.3e-06	8e-05	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—HRAS—peripheral nervous system neoplasm	3.29e-06	0.000187	CbGpPWpGaD
Doxorubicin—Infection—Epirubicin—peripheral nervous system neoplasm	3.28e-06	7.95e-05	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.27e-06	0.000186	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.27e-06	0.000186	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	3.26e-06	0.000186	CbGpPWpGaD
Doxorubicin—Shock—Epirubicin—peripheral nervous system neoplasm	3.25e-06	7.87e-05	CcSEcCtD
Doxorubicin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.24e-06	7.84e-05	CcSEcCtD
Doxorubicin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.23e-06	7.83e-05	CcSEcCtD
Doxorubicin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.22e-06	7.81e-05	CcSEcCtD
Doxorubicin—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	3.22e-06	0.000183	CbGpPWpGaD
Doxorubicin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.21e-06	7.77e-05	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	3.2e-06	0.000182	CbGpPWpGaD
Doxorubicin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.19e-06	7.73e-05	CcSEcCtD
Doxorubicin—NOS3—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.18e-06	0.000181	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.18e-06	0.000181	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—peripheral nervous system neoplasm	3.16e-06	0.00018	CbGpPWpGaD
Doxorubicin—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.15e-06	7.62e-05	CcSEcCtD
Doxorubicin—NQO1—Metabolism—GNAS—peripheral nervous system neoplasm	3.14e-06	0.000179	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—TH—peripheral nervous system neoplasm	3.13e-06	0.000178	CbGpPWpGaD
Doxorubicin—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.09e-06	7.47e-05	CcSEcCtD
Doxorubicin—NQO1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.08e-06	0.000175	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	3.07e-06	0.000175	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GNAS—peripheral nervous system neoplasm	3.03e-06	0.000172	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	3.01e-06	0.000171	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.01e-06	7.29e-05	CcSEcCtD
Doxorubicin—Insomnia—Epirubicin—peripheral nervous system neoplasm	2.99e-06	7.23e-05	CcSEcCtD
Doxorubicin—AKR1C3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.97e-06	0.000169	CbGpPWpGaD
Doxorubicin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	2.97e-06	7.18e-05	CcSEcCtD
Doxorubicin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	2.95e-06	7.13e-05	CcSEcCtD
Doxorubicin—Somnolence—Epirubicin—peripheral nervous system neoplasm	2.94e-06	7.11e-05	CcSEcCtD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.93e-06	0.000167	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—peripheral nervous system neoplasm	2.92e-06	0.000166	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—AKT1—peripheral nervous system neoplasm	2.91e-06	0.000165	CbGpPWpGaD
Doxorubicin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	2.91e-06	7.04e-05	CcSEcCtD
Doxorubicin—AKR1C3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.9e-06	0.000165	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.87e-06	0.000164	CbGpPWpGaD
Doxorubicin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	2.87e-06	6.95e-05	CcSEcCtD
Doxorubicin—ABCC1—Disease—ENO2—peripheral nervous system neoplasm	2.87e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB2—peripheral nervous system neoplasm	2.86e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.86e-06	0.000163	CbGpPWpGaD
Doxorubicin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	2.85e-06	6.9e-05	CcSEcCtD
Doxorubicin—Fatigue—Epirubicin—peripheral nervous system neoplasm	2.85e-06	6.9e-05	CcSEcCtD
Doxorubicin—Pain—Epirubicin—peripheral nervous system neoplasm	2.82e-06	6.84e-05	CcSEcCtD
Doxorubicin—Constipation—Epirubicin—peripheral nervous system neoplasm	2.82e-06	6.84e-05	CcSEcCtD
Doxorubicin—XDH—Metabolism—GNAS—peripheral nervous system neoplasm	2.82e-06	0.00016	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ABCB1—peripheral nervous system neoplasm	2.76e-06	0.000157	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.76e-06	0.000157	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PTPN11—peripheral nervous system neoplasm	2.73e-06	0.000156	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.72e-06	6.59e-05	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	2.7e-06	0.000154	CbGpPWpGaD
Doxorubicin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.7e-06	6.54e-05	CcSEcCtD
Doxorubicin—NOS3—Hemostasis—NRAS—peripheral nervous system neoplasm	2.64e-06	0.00015	CbGpPWpGaD
Doxorubicin—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.62e-06	6.35e-05	CcSEcCtD
Doxorubicin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.61e-06	6.32e-05	CcSEcCtD
Doxorubicin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.61e-06	6.32e-05	CcSEcCtD
Doxorubicin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.61e-06	0.000149	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—peripheral nervous system neoplasm	2.6e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	2.59e-06	0.000147	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.58e-06	0.000147	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.56e-06	0.000146	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GNAS—peripheral nervous system neoplasm	2.56e-06	0.000146	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	2.54e-06	0.000145	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.53e-06	0.000144	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.52e-06	0.000143	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PTPN11—peripheral nervous system neoplasm	2.51e-06	0.000143	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ABCB1—peripheral nervous system neoplasm	2.51e-06	0.000143	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.51e-06	0.000143	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—peripheral nervous system neoplasm	2.48e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.47e-06	0.000141	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.46e-06	0.00014	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.45e-06	0.00014	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.45e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	2.44e-06	0.000139	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.43e-06	5.89e-05	CcSEcCtD
Doxorubicin—ABCC1—Metabolism—ENO2—peripheral nervous system neoplasm	2.4e-06	0.000137	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—peripheral nervous system neoplasm	2.4e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.38e-06	0.000135	CbGpPWpGaD
Doxorubicin—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.37e-06	5.74e-05	CcSEcCtD
Doxorubicin—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.36e-06	0.000134	CbGpPWpGaD
Doxorubicin—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.34e-06	5.66e-05	CcSEcCtD
Doxorubicin—NOS3—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.33e-06	0.000133	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	2.33e-06	0.000132	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC2A1—peripheral nervous system neoplasm	2.31e-06	0.000132	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	2.28e-06	0.00013	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.28e-06	0.00013	CbGpPWpGaD
Doxorubicin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.26e-06	5.47e-05	CcSEcCtD
Doxorubicin—NOS2—Hemostasis—AKT1—peripheral nervous system neoplasm	2.19e-06	0.000125	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.19e-06	0.000125	CbGpPWpGaD
Doxorubicin—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.18e-06	5.29e-05	CcSEcCtD
Doxorubicin—NOS1—Disease—NRAS—peripheral nervous system neoplasm	2.18e-06	0.000124	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB2—peripheral nervous system neoplasm	2.16e-06	0.000123	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.14e-06	0.000122	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTPN11—peripheral nervous system neoplasm	2.12e-06	0.000121	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	2.12e-06	0.00012	CbGpPWpGaD
Doxorubicin—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.1e-06	5.09e-05	CcSEcCtD
Doxorubicin—Rash—Epirubicin—peripheral nervous system neoplasm	2.08e-06	5.04e-05	CcSEcCtD
Doxorubicin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.08e-06	5.04e-05	CcSEcCtD
Doxorubicin—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	2.08e-06	0.000118	CbGpPWpGaD
Doxorubicin—Headache—Epirubicin—peripheral nervous system neoplasm	2.07e-06	5.01e-05	CcSEcCtD
Doxorubicin—TOP2A—Cell Cycle—MYC—peripheral nervous system neoplasm	2.04e-06	0.000116	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	2.04e-06	0.000116	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—BCHE—peripheral nervous system neoplasm	2.03e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—peripheral nervous system neoplasm	2.03e-06	0.000116	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—peripheral nervous system neoplasm	2.02e-06	0.000115	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.99e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.99e-06	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB2—peripheral nervous system neoplasm	1.99e-06	0.000113	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.97e-06	0.000112	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.96e-06	0.000112	CbGpPWpGaD
Doxorubicin—Nausea—Epirubicin—peripheral nervous system neoplasm	1.96e-06	4.75e-05	CcSEcCtD
Doxorubicin—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.95e-06	0.000111	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AKT1—peripheral nervous system neoplasm	1.95e-06	0.000111	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AKT1—peripheral nervous system neoplasm	1.95e-06	0.000111	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.94e-06	0.00011	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—peripheral nervous system neoplasm	1.93e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—TH—peripheral nervous system neoplasm	1.91e-06	0.000109	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.91e-06	0.000109	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.89e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.87e-06	0.000107	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.85e-06	0.000105	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.83e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.81e-06	0.000103	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.79e-06	0.000102	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.78e-06	0.000101	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.78e-06	0.000101	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.76e-06	0.0001	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.74e-06	9.91e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.71e-06	9.7e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.71e-06	9.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—peripheral nervous system neoplasm	1.7e-06	9.69e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.68e-06	9.56e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB2—peripheral nervous system neoplasm	1.68e-06	9.55e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—peripheral nervous system neoplasm	1.68e-06	9.54e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—peripheral nervous system neoplasm	1.64e-06	9.35e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.64e-06	9.34e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.61e-06	9.15e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—peripheral nervous system neoplasm	1.59e-06	9.07e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.58e-06	9.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GNAS—peripheral nervous system neoplasm	1.56e-06	8.87e-05	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—peripheral nervous system neoplasm	1.56e-06	8.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.55e-06	8.83e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.55e-06	8.82e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—peripheral nervous system neoplasm	1.53e-06	8.71e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.53e-06	8.7e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—peripheral nervous system neoplasm	1.51e-06	8.6e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.51e-06	8.58e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.49e-06	8.46e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.48e-06	8.42e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.46e-06	8.31e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—peripheral nervous system neoplasm	1.45e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—peripheral nervous system neoplasm	1.41e-06	8.01e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—peripheral nervous system neoplasm	1.41e-06	8.01e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.4e-06	7.95e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.39e-06	7.91e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	1.37e-06	7.81e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.35e-06	7.66e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.31e-06	7.45e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTPN11—peripheral nervous system neoplasm	1.29e-06	7.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—peripheral nervous system neoplasm	1.28e-06	7.26e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.27e-06	7.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.26e-06	7.18e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.25e-06	7.11e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.23e-06	7.02e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.23e-06	7.01e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—peripheral nervous system neoplasm	1.2e-06	6.84e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—peripheral nervous system neoplasm	1.19e-06	6.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.18e-06	6.69e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.16e-06	6.62e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—peripheral nervous system neoplasm	1.11e-06	6.29e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	1.08e-06	6.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.08e-06	6.13e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.07e-06	6.11e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.07e-06	6.07e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—peripheral nervous system neoplasm	1.06e-06	6.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.06e-06	6.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—peripheral nervous system neoplasm	1.02e-06	5.82e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.01e-06	5.72e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	9.87e-07	5.61e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.85e-07	5.61e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—peripheral nervous system neoplasm	9.76e-07	5.55e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	9.66e-07	5.5e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—peripheral nervous system neoplasm	9.34e-07	5.31e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.22e-07	5.25e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	9.11e-07	5.18e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	9.09e-07	5.17e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	8.94e-07	5.09e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.69e-07	4.94e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	8.56e-07	4.87e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—peripheral nervous system neoplasm	8.47e-07	4.82e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.33e-07	4.74e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—peripheral nervous system neoplasm	8.25e-07	4.69e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—peripheral nervous system neoplasm	8.17e-07	4.65e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.09e-07	4.6e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—peripheral nervous system neoplasm	7.78e-07	4.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.74e-07	4.4e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—peripheral nervous system neoplasm	7.6e-07	4.32e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	7.42e-07	4.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—peripheral nervous system neoplasm	7.25e-07	4.12e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.05e-07	4.01e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	6.99e-07	3.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—peripheral nervous system neoplasm	6.91e-07	3.93e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.86e-07	3.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.84e-07	3.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.83e-07	3.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.54e-07	3.72e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.95e-07	3.39e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.77e-07	3.29e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—peripheral nervous system neoplasm	5.69e-07	3.24e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.68e-07	3.23e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	5.6e-07	3.19e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.6e-07	3.18e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	5.37e-07	3.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—peripheral nervous system neoplasm	5.02e-07	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.57e-07	2.6e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.48e-07	2.55e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—peripheral nervous system neoplasm	4.21e-07	2.39e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	4.07e-07	2.32e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	3.7e-07	2.11e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.71e-07	1.54e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2e-07	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.89e-07	1.07e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-07	7.02e-06	CbGpPWpGaD
